Skip to main content
. 2022 Aug 4;8:351. doi: 10.1038/s41420-022-01145-8

Fig. 4. SLC27A2 functioned as an anti-oncogene and inhibited metastasis and EMT in ccRCC.

Fig. 4

A, B SLC27A2 protein and mRNA expression after overexpression or knockdown. C Cell growth curves of CCK8 assay for indicated cells. D Migration and invasion assays for indicated cells (Magnification: 200×). E GSEA assays for the correlation of EMT signaling pathway and mRNA level of SLC27A2 according to TCGA database. F The expression change of EMT markers in ccRCC cells with overexpressing or knockdown SLC27A2. *p < 0.5, **p < 0.01, ***p < 0.001, and ****p < 0.0001.